Skip to main content
SpringerLink
Log in

Treatment of Fulminant Colitis

  • Chapter
Pediatric Inflammatory Bowel Disease

  • 803 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 179.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Hyams J, Markowitz J, Lerer T, et al. Pediatric Inflammatory Bowel Disease Collaborative Research Group. The natural history of corticosteroid therapy for ulcerative colitis in children. Clin Gastroenterol & Hepatol 4(9):1118–23, 2006.

    Article  CAS  Google Scholar 

  2. Hyams J, Davis P, Grancher K, et al. Clinical outcome of ulcerative colitis in children, J Pediatr 129:81–88, 1996.

    Article  PubMed  CAS  Google Scholar 

  3. Kornbluth A, Sachar DB. Ulcerative colitis: practice guidelines in adults (update): American College of Gastroenterology Practice Parameters Committee. Am J Gastroenterol 99:1371–85, 2004.

    Article  PubMed  Google Scholar 

  4. Markowitz J, Mamula P, Baldassano R, Piccoli D. Ulcerative Colitis. http://www.emedicine.com/ped/topic1183.htm. Last Updated March 1, 2007.

    Google Scholar 

  5. Kugathasan, S, Dubinsky, MC, Keljo, D, et al. Severe Colitis in Children. J Pediatr Gastroenterol Nutr 41(4):375–385, 2005.

    Article  PubMed  Google Scholar 

  6. Kader HA, Mascarenhas MR, Piccoli DA, et al. Experiences with 6-mercaptopurine and azathioprine therapy in pediatric patients with severe ulcerative colitis. J Pediatr Gastroenterol Nutr 28:54–58, 1999.

    Article  PubMed  CAS  Google Scholar 

  7. Bousvaros A, Kirschner BS, Werlin SL, et al. Oral tacrolimus treatment of severe colitis in children. J Pediatr 137(6):794–9, 2000.

    Google Scholar 

  8. Ogata H, Matsui T, Nakamura M, et al. A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis. Gut 55:1255–1262, 2006.

    Google Scholar 

  9. Treem WR, Davis PM, Justinich CJ, Hyams JS. Cyclosporine for the treatment of fulminant ulcerative colitis in children. Immediate response, long-term results, and impact on surgery. Dis Colon Rectum 38(5):474–9, 1995.

    Article  PubMed  CAS  Google Scholar 

  10. McCormack G, McCormick PA, Hyland JM, et al. Cyclosporine therapy in severe ulcerative colitis: is it worth the effort? Dis Colon Rectum 45:1200–5, 2002.

    Article  PubMed  Google Scholar 

  11. Carbonnel F, Boruchowicz A, Duclos B, et al. Intravenous cyclosporine in attacks of ulcerative colitis: short-term and long-term responses. Dig Dis Sci 41:2471–6, 1996.

    Article  PubMed  CAS  Google Scholar 

  12. Arts J, D’Haens G, Zeegers M, et al. Long-term outcome of treatment with intravenous cyclosporine in patients with severe ulcerative colitis, Inflamm Bowel Dis 10:73–8, 2004.

    Article  PubMed  Google Scholar 

  13. Naftali T, Novis B, Pomeranz I, et al. Cyclosporine for severe ulcerative colitis. Isr Med Assoc J 2:588–91, 2000.

    PubMed  CAS  Google Scholar 

  14. Van Assche G, D’Haens G, Noman M, et al. Randomized double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis. Gastroenterology 125:1025–31, 2003.

    Article  PubMed  Google Scholar 

  15. Sandborn WJ. Cyclosporin in ulcerative colitis: state of the art. Act Gastroenterol Beg 64:201–4, 2001.

    CAS  Google Scholar 

  16. Eidelwein AP, Cuffari C, Abadom V, Oliva-Hemker M. Infliximab efficacy in pediatric ulcerative colitis. Inflamm Bowel Dis 11(3):213–8, 2005.

    Article  PubMed  Google Scholar 

  17. Russell GH, Katz AJ. Infliximab is effective in acute but not chronic childhood ulcerative colitis. J Pediatr Gastroenterol Nutr 39(2):166–70, 2004.

    Article  PubMed  CAS  Google Scholar 

  18. Fanjiang G, Russell GH, Katz AJ. Short- and Long-term response to and weaning from infliximab therapy in pediatric ulcerative colitis. J Pediatr Gastro and Nutr 44:312–7, 2007.

    Article  CAS  Google Scholar 

  19. Su C, Salzberg BA, Lewis JD, et al. Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis. Am J Gastroenterol 97:2577–84, 2002.

    Article  PubMed  CAS  Google Scholar 

  20. Mamula P, Markowitz JE, Cohen LJ, von Allmen D, Baldassano RN. Infliximab in pediatric ulcerative colitis: two-year follow-up. J Pediatr Gastroenterol Nutr 38(3):298–301, 2004.

    Article  PubMed  CAS  Google Scholar 

  21. Crandall WV, Mocker LM. Infusion reactions to infliximab in children and adolescents: frequency, outcome and a predictive model. Aliment Pharmacol Ther 17:75–84, 2003.

    Article  PubMed  CAS  Google Scholar 

  22. Fabio, WA. Step-Up Versus Top-Down: Application of New Biological Agents in Pediatric Inflammatory Bowel Disease. Clin Gastroenterol Hepatol 4(9):1094–1096, 2006.

    Article  Google Scholar 

  23. Travis SP, Arrant JM, Ricketts C, et al. Predicting outcome in severe ulcerative colitis. Gut 38:905–10, 1996.

    Article  PubMed  CAS  Google Scholar 

  24. Werlin SL, Grand RJ. Severe colitis in children and adolescents: diagnosis. Course, and treatment. Gastroenterology 73:828–32, 1977.

    PubMed  CAS  Google Scholar 

  25. Hurting WA, Arvanitakis C, Skibba RM, Klotz AP. Treatment of toxic megacolon. A comparative review of 29 patients. Am J Dig Dis 22:195–200, 1977.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pediatric GI Unit-MGH, 175 Cambridge Street-CPZS-560, Boston, MA 02114, USA

    Harland Winter

Authors
  1. Harland Winter
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Attending Physician, Division of GI Hepatology and Nutrition, Director Endoscopy Suite, The Children’s Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA

    Petar Mamula M.D. (Assistant Professor of Pediatrics) (Assistant Professor of Pediatrics)

  2. Attending Physician, Children’s Center for Digestive Health, Greenville Hospital System University Medical Center, University of South Carolina School of Medicine, Greenville, South Carolina, USA

    Jonathan E. Markowitz M.D., M.S.C.E. (Associate Professor of Clinical Pediatrics) (Associate Professor of Clinical Pediatrics)

  3. Attending Physician and Director, Inflammatory Bowel Disease Center Division of GI, Hepatology and Nutrition. The Children’s Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA

    Robert N. Baldassano M.D. (Professor) (Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Winter, H. (2008). Treatment of Fulminant Colitis. In: Mamula, P., Markowitz, J.E., Baldassano, R.N. (eds) Pediatric Inflammatory Bowel Disease. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-73481-1_34

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-73481-1_34

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-73480-4

  • Online ISBN: 978-0-387-73481-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation